Asset Details
Do you wish to reserve the book?
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
Do you wish to request the book?
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
2019
Overview
Robust anti-tumor immunity requires innate as well as adaptive immune responses. We have shown that plasmacytoid dendritic cells develop killer cell-like activity in melanoma cell cocultures after exposure to the infectious but replication-deficient herpes simplex virus 1 (HSV-1)
106S. To combine this innate effect with an enhanced adaptive immune response, the gene encoding human MelanA/MART-1 was inserted into HSV-1
106S via homologous recombination to increase direct expression of this tumor antigen. Infection of Vero cells using this recombinant virus confirmed MelanA expression by Western blotting, flow cytometry, and immunofluorescence. HSV-1
106S-MelanA induced expression of the transgene in fibroblast and melanoma cell lines not naturally expressing MelanA. Infection of a melanoma cell line with CRISPR-Cas9-mediated knockout of MelanA confirmed
expression of the transgene in the viral context. Dependent on MelanA expression, infected fibroblast and melanoma cell lines induced degranulation of HLA-matched MelanA-specific CD8
T cells, followed by killing of infected cells. To study infection of immune cells, we exposed peripheral blood mononuclear cells and
-differentiated macrophages to the parental HSV-1
106S, resulting in expression of the transgene GFP in CD11c
cells and macrophages. These data provide evidence that the application of MelanA-encoding HSV-1
106S could enhance adaptive immune responses and re-direct MelanA-specific CD8
T cells to tumor lesions, which have escaped adaptive immune responses via downregulation of their tumor antigen. Hence, HSV-1
106S-MelanA harbors the potential to induce innate immune responses in conjunction with adaptive anti-tumor responses by CD8
T cells, which should be evaluated in further studies.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Agonists
/ Antigen-Presenting Cells - immunology
/ Antigen-Presenting Cells - metabolism
/ Antigens
/ CD8-Positive T-Lymphocytes - immunology
/ CD8-Positive T-Lymphocytes - metabolism
/ CRISPR
/ Genes
/ Herpesvirus 1, Human - genetics
/ Humans
/ Leukocytes, Mononuclear - immunology
/ Leukocytes, Mononuclear - metabolism
/ Melanoma
/ Oncolytic Viruses - genetics
/ Peptides
/ Peripheral blood mononuclear cells
/ Phenols
/ Plasmids
/ Tumors
/ vaccine
/ Viruses
